4.5 Review

The search for endogenous activators of the aryl hydrocarbon receptor

Journal

CHEMICAL RESEARCH IN TOXICOLOGY
Volume 21, Issue 1, Pages 102-116

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/tx7001965

Keywords

-

Funding

  1. NCI NIH HHS [P30-CA014520, P30 CA014520, P30 CA014520-299026, T32-CA009135] Funding Source: Medline
  2. NIEHS NIH HHS [R01 ES005703, R37-ES005703, R01 ES005703-10] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703, R37ES005703] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The primary design of this perspective is to describe the major ligand classes of the aryl hydrocarbon receptor (AHR). A grander objective is to provide models that may help define the physiological activator or endogenous ligand of the AHR. We present evidence supporting a developmental role for the AHR and propose mechanisms by which an endogenous ligand and consequent AHR activation might be important during normal physiology and development. From this vista, we survey the known xenobiotic, endogenous, dietary, and unconventional activators of the AHR, including, when possible, information about their induction potency, receptor binding affinity, and potential for exposure. In light of the essential function of the AHR in embryonic development, we discuss the candidacy of each of these compounds as physiologically important activators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available